[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]

September 2017, Vol 74, No. 9, Pages 1-975

In This Issue of JAMA Psychiatry

Highlights

Abstract Full Text
free access
JAMA Psychiatry. 2017;74(9):861. doi:10.1001/jamapsychiatry.2016.2536
Viewpoint

A Mitochondrial Etiology of Neuropsychiatric Disorders

Abstract Full Text
JAMA Psychiatry. 2017;74(9):863-864. doi:10.1001/jamapsychiatry.2017.0397

This Viewpoint explores the hypothesis that mitochondrial dysfunction is associated with neuropsychiatric disorders.

Clinical Care Across CulturesWhat Helps, What Hinders, What to Do

Abstract Full Text
JAMA Psychiatry. 2017;74(9):865-866. doi:10.1001/jamapsychiatry.2017.1994

This Viewpoint encourages clinicians to have a greater awareness of the needs of patients from diverse backgrounds to provide better care.

Editorial

Transdiagnostic Cognitive Behavioral Therapy and the Return of the Repressed

Abstract Full Text
JAMA Psychiatry. 2017;74(9):867-868. doi:10.1001/jamapsychiatry.2017.1982

Remarkable Increases in Alcohol Use Disorders

Abstract Full Text
JAMA Psychiatry. 2017;74(9):869-870. doi:10.1001/jamapsychiatry.2017.1981

Suicidal Behaviors Within Army UnitsContagion and Implications for Public Health Interventions

Abstract Full Text
JAMA Psychiatry. 2017;74(9):871-872. doi:10.1001/jamapsychiatry.2017.1908

Interactional Dysfunction of the Social Brain in a Paradigmatic Relational DisorderFrom One Island to Another

Abstract Full Text
JAMA Psychiatry. 2017;74(9):873-874. doi:10.1001/jamapsychiatry.2017.1633
Original Investigation

Association of Cost Sharing With Mental Health Care Use, Involuntary Commitment, and Acute Care

Abstract Full Text
open access
JAMA Psychiatry. 2017;74(9):1-9. doi:10.1001/jamapsychiatry.2017.1847

This study examines the association of higher patient cost sharing with mental health care use and downstream effects, such as involuntary commitment and acute mental health care use.

The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety DisordersA Randomized Clinical Trial

Abstract Full Text
JAMA Psychiatry. 2017;74(9):875-884. doi:10.1001/jamapsychiatry.2017.2164

This randomized clinical equivalence trial examines whether the Unified Protocol is at least as efficacious as single-disorder protocols in the treatment of anxiety disorders.

Efficacy of Tramadol Extended-Release for Opioid WithdrawalA Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA Psychiatry. 2017;74(9):885-893. doi:10.1001/jamapsychiatry.2017.1838

This randomized clinical trial compares the use of tramadol extended-release with clonidine and buprenorphine in treatment of withdrawal symptoms in patients with opioid use disorder.

Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use DisorderA Randomized Clinical Trial

Abstract Full Text
JAMA Psychiatry. 2017;74(9):894-902. doi:10.1001/jamapsychiatry.2017.1874

This randomized clinical trial evaluates the ability of a novel subcutaneous buprenorphine depot formulation (CAM2038) to block euphorigenic opioid effects and suppress opioid withdrawal in nontreatment-seeking individuals with opioid use disorder.

Efficacy of Lisdexamfetamine in Adults With Moderate to Severe Binge-Eating DisorderA Randomized Clinical Trial

Abstract Full Text
open access
JAMA Psychiatry. 2017;74(9):903-910. doi:10.1001/jamapsychiatry.2017.1889

This randomized clinical trial evaluates the maintenance of efficacy of lisdexamfetamine dimesylate vs placebo after withdrawal in binge-eating disorder.

Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013Results From the National Epidemiologic Survey on Alcohol and Related Conditions

Abstract Full Text
JAMA Psychiatry. 2017;74(9):911-923. doi:10.1001/jamapsychiatry.2017.2161

This study presents findings from interviews conducted in 2 US national surveys and reports changes in the prevalences of 12-month alcohol use, high-risk drinking, DSM-IV alcohol use disorder between 2001-2002 and 2012-2013.

Risk of Suicide Attempt Among Soldiers in Army Units With a History of Suicide Attempts

Abstract Full Text
free access
JAMA Psychiatry. 2017;74(9):924-931. doi:10.1001/jamapsychiatry.2017.1925

This cohort study examines whether a US Army soldier’s suicide attempt risk is associated with previous suicide attempts in that soldier’s unit.

Comparing Public Safety Outcomes for Traditional Probation vs Specialty Mental Health Probation

Abstract Full Text
JAMA Psychiatry. 2017;74(9):942-948. doi:10.1001/jamapsychiatry.2017.1384

This longitudinal study assesses whether specialty probation yields better public safety outcomes than traditional probation for individuals with mental illness.

State-Dependent Cross-Brain Information Flow in Borderline Personality Disorder

Abstract Full Text
JAMA Psychiatry. 2017;74(9):949-957. doi:10.1001/jamapsychiatry.2017.1682

This cohort study applies recent advancements in the investigation of 2-person human social interaction to examine interaction difficulties among people with borderline personality disorder.

Association of White Matter With Core Cognitive Deficits in Patients With Schizophrenia

Abstract Full Text
JAMA Psychiatry. 2017;74(9):958-966. doi:10.1001/jamapsychiatry.2017.2228

This cross-sectional study uses a large sample of patients with schizophrenia and healthy controls to determine the association of white matter with information processing speed and working memory.

Invited Commentary

Cost Sharing and Mental Health CareA Cautionary Tale From the Netherlands

Abstract Full Text
JAMA Psychiatry. 2017;74(9):940-941. doi:10.1001/jamapsychiatry.2017.1837
Research Letter

Assessment of Insulin Resistance Among Drug-Naive Patients With First-Episode Schizophrenia in the Context of Hormonal Stress Axis Activation

Abstract Full Text
JAMA Psychiatry. 2017;74(9):968-970. doi:10.1001/jamapsychiatry.2017.1983

This study assesses homeostatic model assessment of insulin resistance and stress hormone levels among drug-naive patients with first-episode schizophrenia.

Comment & Response

Ketamine for the Treatment of Depression

Abstract Full Text
JAMA Psychiatry. 2017;74(9):970. doi:10.1001/jamapsychiatry.2017.1770

Ketamine for the Treatment of Depression

Abstract Full Text
JAMA Psychiatry. 2017;74(9):970-971. doi:10.1001/jamapsychiatry.2017.1773

Ketamine for the Treatment of Depression—Reply

Abstract Full Text
JAMA Psychiatry. 2017;74(9):971-972. doi:10.1001/jamapsychiatry.2017.1776

Ketamine for the Treatment of Depression

Abstract Full Text
JAMA Psychiatry. 2017;74(9):971. doi:10.1001/jamapsychiatry.2017.1779

The Importance of a Valid Comparison Group

Abstract Full Text
JAMA Psychiatry. 2017;74(9):972-973. doi:10.1001/jamapsychiatry.2017.2219

The Importance of a Valid Comparison Group—Reply

Abstract Full Text
JAMA Psychiatry. 2017;74(9):973-974. doi:10.1001/jamapsychiatry.2017.1556

Ineffective Policies to Address the Opioid Epidemic—Reply

Abstract Full Text
JAMA Psychiatry. 2017;74(9):974-975. doi:10.1001/jamapsychiatry.2017.1668

Ineffective Policies to Address the Opioid Epidemic

Abstract Full Text
JAMA Psychiatry. 2017;74(9):974. doi:10.1001/jamapsychiatry.2017.2216
Correction

Errors in Abstract and Discussion

Abstract Full Text
free access
JAMA Psychiatry. 2017;74(9):975. doi:10.1001/jamapsychiatry.2017.2809
JAMA Psychiatry Masthead

JAMA Psychiatry

Abstract Full Text
free access
JAMA Psychiatry. 2017;74(9):862. doi:10.1001/jamapsychiatry.2016.2537
×